Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-21-004605)

Filing Details

Accession Number:: 0001179110-21-004605
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-26 16:16:03
Reporting Period:: 2021-04-23

Accepted Time:: 2021-04-26 16:16:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1724521	Arcus Biosciences Inc.	RCUS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1277503	Yasunori Kaneko	C/O Arcus Biosciences, Inc. 3928 Point Eden Way Hayward CA 94545		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-23	4,133	$31.37	7,133	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	505,050	Indirect	By Kaneko Capital, LLC
Common Stock	252,524	Indirect	By Kaneko Investments, LLC
Common Stock	131,948	Indirect	By Trust

Footnotes

Shares purchased in a private transaction from Dr. William Grossman, Arcus's Chief Medical Officer.
Thirty-five thousand (35,000) shares previously held directly by the reporting person were transferred to reporting person's trust.
The reporting person's direct ownership includes three thousand (3,000) shares that are Restricted Stock Units that will not vest until June 3, 2021.